TY - JOUR
T1 - Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population
AU - Kishi, Taro
AU - Kitajima, Tsuyoshi
AU - Tsunoka, Tomoko
AU - Okumura, Takenori
AU - Ikeda, Masashi
AU - Okochi, Tomo
AU - Kinoshita, Yoko
AU - Kawashima, Kunihiro
AU - Yamanouchi, Yoshio
AU - Ozaki, Norio
AU - Iwata, Nakao
N1 - Funding Information:
Acknowledgments We thank Ms M. Miyata and Ms S. Ishihara for their technical support. This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Health, Labor and Welfare, and the Japan Health Sciences Foundation (Research on Health Sciences focusing on Drug Innovation).
PY - 2009/6
Y1 - 2009/6
N2 - Several investigations have suggested that disruption of circadian rhythms may provide the foundation for the development of mood disorders such as bipolar disorder (BP) and major depressive disorder (MDD). Recent animal studies reported that prokineticin 2 or prokineticin 2 receptor gene deficient mice showed disruptions in circadian and homeostatic regulation of sleep. This evidence indicates that prokineticin 2 gene (PROK2) and prokineticin 2 receptor gene (PROKR2) are good candidate genes for the pathogenesis of mood disorders. To evaluate the association between PROK2, PROKR2, and mood disorders, we conducted a case-control study of Japanese samples (151 bipolar patients, 319 major depressive disorder patients, and 340 controls) with four and five tagging SNPs in PROK2 or PROKR2, respectively, selected by HapMap database. We detected a significant association between PROKR2 and major depressive disorder and bipolar disorder in the Japanese population. In conclusion, our findings suggest that PROKR2 may play a role in the pathophysiology of mood disorders in the Japanese population. However, because our samples were small, it will be important to replicate and confirm these findings in other independent studies using larger samples.
AB - Several investigations have suggested that disruption of circadian rhythms may provide the foundation for the development of mood disorders such as bipolar disorder (BP) and major depressive disorder (MDD). Recent animal studies reported that prokineticin 2 or prokineticin 2 receptor gene deficient mice showed disruptions in circadian and homeostatic regulation of sleep. This evidence indicates that prokineticin 2 gene (PROK2) and prokineticin 2 receptor gene (PROKR2) are good candidate genes for the pathogenesis of mood disorders. To evaluate the association between PROK2, PROKR2, and mood disorders, we conducted a case-control study of Japanese samples (151 bipolar patients, 319 major depressive disorder patients, and 340 controls) with four and five tagging SNPs in PROK2 or PROKR2, respectively, selected by HapMap database. We detected a significant association between PROKR2 and major depressive disorder and bipolar disorder in the Japanese population. In conclusion, our findings suggest that PROKR2 may play a role in the pathophysiology of mood disorders in the Japanese population. However, because our samples were small, it will be important to replicate and confirm these findings in other independent studies using larger samples.
UR - http://www.scopus.com/inward/record.url?scp=70349780141&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70349780141&partnerID=8YFLogxK
U2 - 10.1007/s12017-009-8067-0
DO - 10.1007/s12017-009-8067-0
M3 - Article
C2 - 19544013
AN - SCOPUS:70349780141
SN - 1535-1084
VL - 11
SP - 114
EP - 122
JO - NeuroMolecular Medicine
JF - NeuroMolecular Medicine
IS - 2
ER -